There are 2789 resources available
1673P - Efficacy and safety of 5 mg olanzapine for the prevention of carboplatin-induced nausea and vomiting in patients with thoracic malignancies: A prospective multicenter phase II study
Presenter: Yukiyoshi Fujita
Session: ePoster Display
1674P - Does body mass index (BMI) affect the type of response to anamorelin (ANAM) over time? Focus on body composition and anorexia symptoms and concerns
Presenter: David Currow
Session: ePoster Display
1540P - Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study
Presenter: Margaret von Mehren
Session: ePoster Display
1541P - Real-world data from patients with gastrointestinal stromal tumors (GIST) treated in Dutch GIST expertise centers
Presenter: Nikki IJzerman
Session: ePoster Display
1542P - Kaposi sarcoma: A population-based study of secondary primary neoplasms
Presenter: Gabriel Hanna
Session: ePoster Display
Resources:
Abstract
1543P - Gemcitabine in classic Kaposi’s sarcoma: A pilot study
Presenter: Giuseppe Badalamenti
Session: ePoster Display
1544P - Soft tissue sarcoma (STS) incidences and clinical characteristics are significantly different between different geographic and ethnic populations
Presenter: Tom Wei-Wu Chen
Session: ePoster Display
1545P - Initial presentation of sarcomas in adult patients from private and public health insurance systems in Brazil: A single center analysis
Presenter: Celso Filho
Session: ePoster Display
1546P - Therapeutic strategies for uterine PEComas
Presenter: Chiara Cimmino
Session: ePoster Display
1547P - Trabectedin in soft-tissue sarcoma patients in Italy: Analysis of real-world data from a national registry
Presenter: Bruno Vincenzi
Session: ePoster Display